Therapeutic Goods Administration (TGA)
We are Australia's government authority responsible for evaluating, assessing and monitoring products that are defined as therapeutic goods. We regulate medicines, medical devices and biologicals to help Australians stay healthy and safe.
Search for health products on our register
Search the Australian Register of Therapeutic Goods (ARTG) by name, ID or sponsor. Search results from the ARTG include Consumer Medicines Information (CMI) and Product Information (PI). Not all CMI and PI documents are available on this website.
Frequently searched by industry
Frequently searched by health professionals
Latest alerts
- Hydrocortisone shortageThe TGA is aware of a shortage of all hydrocortisone tablet strengths due to manufacturing issues. We are working with the supplier Alphapharm Pty Ltd to manage the impact.
- Substitution instrument to address shortage of COUMADIN warfarin 5mg tabletsAs the shortage of Coumadin 5mg tablets is expected to continue, the TGA has made a Serious Scarcity Substitution Instrument to assist patients to access their medicine from their pharmacist without delay or interruption to treatment.
- PholcodineThe TGA has decided to cancel the registration of pholcodine-containing medicines and is recalling them from pharmacies.
Latest news and updates
Understanding the changes to MDMA and psilocybin accessFind out about the safety controls that will be in place before authorised psychiatrists can prescribe psychedelic medicines to people with specific mental health conditions.- Changes to medical device essential principles for nanomaterialsEssential principle 7 now mentions nanomaterials explicitly (see EP 7.7)
- Company director sentenced to 2 years imprisonment with personal and company fines of over $2.5 million for selling illegal SARMsChristopher Ramsey, the Director of AusLabs, Smart Labs and iSARMs, has been sentenced 2 years imprisonment and fined $300,000 for his role in the manufacture, supply and advertising of illegal Selective Androgen Receptor Modulators and nootropic products. Mr Ramsey’s three companies also received significant fines totalling $2,225,000.